Cart
sales@molnova.com
Divaplon
CAS No. 90808-12-1
Divaplon( —— )
Catalog No. M34226 CAS No. 90808-12-1
Divaplon is a GABA receptor agonist (IC50: 0.056 μM) that exhibits non-sedating anxiolytic properties in a rat model of anxiety.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 222 | Get Quote |
|
| 5MG | 333 | Get Quote |
|
| 10MG | 504 | Get Quote |
|
| 25MG | 790 | Get Quote |
|
| 50MG | 1086 | Get Quote |
|
| 100MG | 1431 | Get Quote |
|
| 500MG | 2871 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameDivaplon
-
NoteResearch use only, not for human use.
-
Brief DescriptionDivaplon is a GABA receptor agonist (IC50: 0.056 μM) that exhibits non-sedating anxiolytic properties in a rat model of anxiety.
-
DescriptionDivaplon is a GABA receptor agonist (IC50: 0.056 μM) that exhibits non-sedating anxiolytic properties in a rat model of anxiety.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorGABA Receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number90808-12-1
-
Formula Weight295.34
-
Molecular FormulaC17H17N3O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC=1N2C(=NC(C(=O)C3=CC=CC=C3)=C2)N=C(OC)C1CC
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
MI-3454
MI-3454 is an orally active, selective and potent inhibitor of Menin-MLL1 interaction that inhibits the proliferation and induces differentiation of acute leukemia cells with MLL1 translocation or NPM1 mutation.
-
Cannabichromenic aci...
Cannabichromenic acid is a new antibiotic active against gram-positive bacteria, including MRSA.
-
5-O-Coumaroylquinic ...
5-O-Coumaroylquinic acid has a considerable inhibitory effect on PTP1B.5-O-Coumaroylquinic acid( 3-O-Coumaroylquinic acid) shows a significant concentration-dependent inhibitory effect on α-glucosidase, so it has anti-hyperglycemic effect.5-O-Coumaroylquinic acid(3-O-Coumaroylquinine acid) enhances glucose uptake and inhibits PTP1B in vitro.
